As an oncogene, geminin is overexpressed in tumors, which is linked to the prognosis of colon, rectal, and breast cancers (Montanari et al., 2005; Hernández-Pérez et al., 2017; Zhang et al., 2017). The gene discussed is GMNN; the disease is breast carcinoma.